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ABSTRACT
Objective: Alcohol accumulation in the liver can cause pathological disorders such as liver fibrosis that can develop into hepatocellular carcinoma, 
one of the main causes of mortality associated with liver disease. The previous studies have shown that a plant compound, alpha-mangostin, has an 
antioxidant effect in the inhibition of pancreatic tumor growth in vitro. This study aimed to analyze the antioxidative properties of alpha-mangostin in 
acetaldehyde-induced liver fibrosis in vitro.
Methods: Immortalized hepatic stellate cells (HSCs), of the LX-2 cell line, were incubated with acetaldehyde in the presence or absence of alpha-
mangostin (10 and 20 μM). The cells were then counted and lysed, and LX-2 cell viability was determined with the trypan blue exclusion method. The 
malondialdehyde levels, superoxide dismutase activity, and glutathione (GSH) levels were also determined using the cell lysates.
Results: Acetaldehyde treatment resulted in a significant increase in HSC cell viability and decreased the production of GSH. Alpha-mangostin 
treatment resulted in reduced cell viability of the HSCs and prevention of the loss of intracellular GSH.
Conclusion: Alpha-mangostin reduced acetaldehyde-induced cell proliferation, and this was affected at least in part by its antioxidative properties.
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INTRODUCTION
Alcohol accumulation in the liver can cause pathological disorders 
such as liver fibrosis. This disease can develop into hepatocellular 
carcinoma, which is one of the main causes of mortality associated 
with liver disease [1,2]. Hepatic stellate cells (HSCs) are central to the 
development of fibrosis following alcohol accumulation. In the normal 
liver, HSCs are quiescent cells that differentiate into myofibroblasts 
when activated. Other than alcohol, HSC can be activated by toxins, 
disorders of immune systems, or viral and parasitic infections. Active 
HSCs are characterized by increased proliferation, contractility, and 
secretion of the fibrogenesis mediator, transforming growth factor β 
(TGF-β) [3-5].
Alcohol is metabolized in the liver by alcohol dehydrogenase to produce 
acetaldehyde, a toxic substance, which further metabolized to form 
acetate, a less active byproduct. When there is a large amount of alcohol, 
CYP2E1 will also active and metabolize alcohol to acetaldehyde and 
further produce acetate and reactive oxygen species (ROS) [6,7]. ROS 
enhance HSC activation and play an important role in the fibrogenesis 
that occurs in alcohol-induced liver disease. TGF-β increases the 
production of ROS and suppresses the production of antioxidants. ROS, 
in turn, activates latent TGF-β and induces its expression. Consequently, 
TGF-β acts synergistically with alcohol in inducing oxidative stress, thus 
increasing alcohol-induced liver damage [8,9].
There is no standard therapy for the treatment of liver fibrosis. Research 
on the treatment of liver fibrosis using active compounds from plants 
is still ongoing. Alpha-mangostin, one of the main xanthones from 
Garcinia mangostana, is known to have anti-inflammatory, antioxidant, 
cardioprotective, antidiabetic, and anticancer properties [10,11]. In a 
previous study by Rahmaniah et al., alpha-mangostin was shown to 
decrease the ratios of pSmad/Smad and pAkt/Akt in an in vitro liver 
fibrosis model induced by TGF-β [12]. Further, investigations of the 
mechanism of the action of alpha-mangostin as a hepatoprotector are 
still required. This study aimed to analyze the antioxidant activity of 
alpha-mangostin in a model of acetaldehyde-induced liver fibrosis.
METHODS
Human HSCs, of the LX-2 cell line, were purchased from Millipore 
(USA; Cat. No. SCC064). Alpha-mangostin was obtained from Santa 
Cruz Biotechnology (Texas, USA). Acetaldehyde and dimethylsulfoxide 
(DMSO) were purchased from Sigma-Aldrich (Singapore). Dulbecco’s 
modified Eagle’s Medium (DMEM) high glucose-supplemented media, 
heat-inactivated fetal bovine serum (FBS), penicillin, streptomycin, and 
Fungizone were obtained from Biowest (USA). Thermo Scientific Cell 
Extraction Buffer (Cat No FNN0011) and the Coomassie Plus (Bradford) 
Assay kit were obtained from Invitrogen (USA).
LX-2 culture
LX-2 cells were cultured and maintained at 37°C in 5% CO2 in DMEM 
high glucose supplemented media containing 10% heat-inactivated FBS, 
10 U/L penicillin, 100 μg/mL streptomycin, and 2.5 μg/mL Fungizone.
Cell treatments
Cells were divided into five groups and seeded at 2 × 106 each in 10-cm 
culture dishes. Two groups comprised the untreated cells (medium 
with DMSO only), whereas the other three groups were subjected to 
various treatments for 24 h. To the first of the treated groups of cells, 
acetaldehyde (100 μM) was applied; to the second and third groups of 
treated cells, acetaldehyde (100 μM) plus alpha-mangostin (10 μM) and 
acetaldehyde (100 μM) plus alpha-mangostin (20 μM) were applied, 
respectively. To the fifth group, only alpha-mangostin (10 μM) was 
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applied. After 24 h of treatment, the cells were harvested and subjected 
to analysis of cell viability, and the proteins were extracted for 
antioxidant analysis. Cell viability was examined with the trypan blue 
exclusion method. All experiments were performed in triplicate.
Spectrophotometry analysis
The malondialdehyde (MDA) levels in the cell medium were determined 
in a microplate reader using colorimetric method described by Siddique 
et al. [13], while glutathione (GSH) levels were measured using Reduced 
GSH Assay Kit (Elabscience, USA). Activity of superoxide dismutase 
(SOD) in cell lysates was measured using the method of Misra and 
Fridovich [14].
Statistical analysis
Results are presented as the mean±Standard error of the mean. 
Statistical analysis was performed with one-way analysis of variance. 
All values with p<0.05 were considered statistically significant.
RESULTS
Cell morphology
After 48 h of treatment of the acetaldehyde-induced LX-2 cells with or 
without alpha-mangostin, no changes in morphology were observed 
under an inverted microscope (Fig. 1).
Cell viability
Acetaldehyde induction at 100 μM resulted in a significant increase 
(p<0.05) in LX-2 proliferation compared with the control group (Fig. 2). 
In contrast, alpha-mangostin treatment significantly suppressed 
(p<0.05) acetaldehyde-induced LX-2 proliferation in a dose-dependent 
manner.
Alpha-mangostin restores MDA levels in the LX-2 culture medium 
after acetaldehyde induction
Induction with 100 μM acetaldehyde slightly increased MDA levels in 
the LX-2 culture medium compared with the control group, whereas 
treatment with alpha-mangostin restores MDA accumulation (Fig. 3).
Alpha-mangostin significantly increased GSH levels
Induction with 100 μM acetaldehyde significantly decreased the 
GSH levels (p<0.05) and SOD activity (not statistically significant) of 
LX-2 cells compared with the control group, whereas alpha-mangostin 
significantly enhanced (p<0.05) the GSH level (Fig. 4).
DISCUSSION
In this study, no change was observed in the morphology of the LX-2 cells 
between the control and treatment groups because the cells were 
already activated with a myofibroblast-like phenotype. Acetaldehyde 
was, however, observed to enhance HSC proliferation by increasing 
Fig. 2: Effect of alpha-mangostin on hepatic stellate cells 
proliferation. Cell viability of the LX-2 cells was determined 
after induction with acetaldehyde and treatment with alpha-
mangostin. Normal: Control group; Acetaldehyde: Induced 
with 100 μM acetaldehyde; Acetaldehyde+AM10: Treated with 
10 μM alpha-mangostin and induced with 100 μM acetaldehyde; 
Acetaldehyde+AM20: Treated with 20 μM alpha-mangostin and 
induced with 100 μM acetaldehyde; AM 10: Treatment with 10 μM 
alpha-mangostin only (no induction). Results are presented as 
the mean ± SE. *p<0.05 versus normal group; #p<0.05 versus 
acetaldehyde group
Fig. 3: Effect of alpha-mangostin on malondialdehyde (MDA) 
levels. The MDA level in LX-2 cells was determined after 
acetaldehyde induction and treatment with alpha-mangostin. 
Normal: Control group; Acetaldehyde: Induced with 100 μM 
acetaldehyde; Acetaldehyde+AM10: Treated with 10 μM 
alpha-mangostin and induced with 100 μM acetaldehyde; 
Acetaldehyde+AM20: Treated with 20 μM alpha-mangostin and 
induced with 100 μM acetaldehyde; AM 10: Treatment with 10 μM 
alpha-mangostin only (no induction). Results are presented as 
the mean±Standard error of the mean
Fig. 1: Treatment of acetaldehyde-induced LX-2 cells with 
alpha-mangostin. Following 48 h of treatment, morphological 
observation of the LX-2 cells was performed with an inverted 
microscope. The treated LX-2 cells did not exhibit any 
morphological changes (10× magnification). (a) Control group 
(normal media only), (b) 100 μM acetaldehyde induction, 
(c) treatment with 10 μM alpha-mangostin and induction with 
100 μM acetaldehyde, (d) treatment with 20 μM alpha-mangostin 
and induction with 100 μM acetaldehyde, and (e) treatment with 
10 μM alpha-mangostin (no acetaldehyde induction)
a b c
d e
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cell viability. This result was in line with research conducted by Wang 
et al. and Zhang et al., which showed that acetaldehyde significantly 
increases HSC viability [15,16].
Acetaldehyde was known to elevate intracellular HSC ROS production 
and oxidative stress which leads to HSC activation promoting 
fibrogenesis [8,9]. The effects of acetaldehyde on the oxidative stress 
of HSC cells were studied in this research. Exposure to acetaldehyde 
caused an increase in the production of ROS in the HSCs, as indicated 
by a decrease in the concentration of GSH and the activity of SOD, both 
of which are important in the detoxification of ROS [17]. The effect 
of alpha-mangostin activity on these processes was then analyzed at 
two concentrations (10 and 20 μM), and this compound was found to 
significantly increase the levels of GSH. These concentrations of alpha-
mangostin were chosen on the basis of previous research conducted 
by Rahmaniah et al., who reported a 50% cytotoxic concentration for 
alpha-mangostin in LX-2 cells of 10.77 μM [12].
MDA is a metabolite formed by lipid peroxidation of the cell membrane. 
Increased levels of MDA indicate the presence of lipid damage to the 
cell membrane due to oxidative stress [18]. MDA is, therefore, generally 
considered to be a marker of intracellular oxidative stress and an 
indicator of lipid peroxidation [17]. In this study, MDA levels were 
observed to increase in the acetaldehyde-induced group. On the other 
hand, alpha-mangostin antioxidant activity was expected to prevent 
this elevation; although there was no significant difference, alpha-
mangostin did reduce the MDA levels in a dose-dependent manner.
GSH is an intracellular antioxidant that helps mitigate the oxidative 
stress caused by various ROS sources. Decreased cellular GSH levels 
indicate that the cell is experiencing oxidative stress caused by ROS, 
which requires neutralization by GSH. SOD is an antioxidant enzyme 
that protects cells from oxidative stress by catalyzing the process of 
superoxide dismutation into oxygen and hydrogen peroxide. Decreased 
SOD activity indicates the presence of oxidative stress caused by 
superoxide [19]. In this study, the antioxidant activity of alpha-
mangostin was illustrated by the prevention of cellular GSH loss and 
increased SOD activity.
The use of antioxidants alone for the treatment of liver disease caused 
by alcohol is still controversial. The results of clinical trials indicate that 
antioxidants can be used for prevention but are not effective for the 
treatment of alcohol-related liver fibrosis [20]. The mechanisms and 
effects of acetaldehyde induction should be further assessed in future 
studies by examining changes in specific biomarkers. Further, research 
is also required to elucidate the mechanisms underlying the activity of 
alpha-mangostin and to develop its potential as an antifibrotic.
CONCLUSION
Alpha-mangostin was shown to normalize cell viability in HSCs induced 
by acetaldehyde, which at least in part resulted from protective effect of 
alpha-mangostin in preventing the loss of intracellular GSH.
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